Clinical Trial
Study Details
Enrollment
21
Interventions
Name
NKTT120
Type
Drug
Phase
Phase 1
Status
COMPLETED
Study ID #
NCT01783691
Study Type
Interventional
Summary
The purpose of this study is to determine the safety, pharmacokinetics, and pharmacodynamics of NKTT120 in adult patients with stable sickle cell disease.
Study Overview
Conditions
Contacts and Locations
Locations
Facility
Children's Hospital & Research Center at Oakland
Oakland, California 94609
United States
GeoPoint
37.80437, -122.2708
Facility
Johns Hopkins School of Medicine
Baltimore, Maryland 21205
United States
GeoPoint
39.29038, -76.61219
Facility
Brigham and Women's Hospital
Boston, Massachusetts 02115
United States
GeoPoint
42.35843, -71.05977
Facility
Washington University School of Medicine
St Louis, Missouri 63110
United States
GeoPoint
38.62727, -90.19789
Facility
UNC Sickle Cell Program
Chapel Hill, North Carolina 27514
United States
GeoPoint
35.9132, -79.05584
Facility
Blood Center of Wisconsin
Milwaukee, Wisconsin 53226
United States
GeoPoint
43.0389, -87.90647